Patents
Sitemap › C07 - Organic chemistry › C07C - Acyclic or carbocyclic compounds › C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
Patents for C07C 217 - Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton (13,958)
06/2005
06/07/2005US6903220 Synthesis of chiral 2-alkyl amino acids
06/02/2005WO2005049560A2 Process for the preparation of anti-depressant compound
06/02/2005US20050119502 (Dialkylamino, morpholino, or imidazolyl)-alkoxyphenolic derivatives as drug delivery agents; improved bioavailability for oral administration
06/02/2005US20050119349 Process for chlorinating tertiary alcohols
06/02/2005US20050119315 Cardiovascular disorders; antiarrhythmia agents; sodium channel moderators; potassium channel moderators; prevention fibrillation
06/02/2005US20050119264 Tetrahydrobenzfluorene derivatives
06/02/2005US20050119225 Phosphodiesterase 4 inhibitors, including N-substituted aniline and diphenylamine analogs
06/01/2005EP1535899A1 Dyeing composition comprising at least one tertiary particular p-phenylenediamine, colouring method using same
06/01/2005EP1535897A1 Intermediates in producing phenoxyacetic acid derivatives and method of using the same
06/01/2005EP1535889A1 Method of deuterating aromatic ring
06/01/2005EP1534664A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides
06/01/2005EP1115695B1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity
06/01/2005CN1204262C Method for producing optically active amines
05/2005
05/31/2005US6900244 Controlling lipid, cholesterol metabolism; anticholesterol agents
05/31/2005US6900243 Phenylheteroalkylamine derivatives
05/31/2005US6900203 Optically active fluorinated vasoconstrictors, methods for making them, and anesthetic formulations comprising them
05/28/2005CA2486825A1 Specific tertiary p-phenylenediamine, dyeing composition containing same and colouring process using said composition
05/26/2005WO2005047249A1 Benzylether amine compounds useful as ccr-5 antagonists
05/26/2005WO2005047233A1 Novel herbicides
05/26/2005WO2005046568A2 Process for manufacture of metoprolol and salts thereof
05/26/2005US20050113580 2-(3-{3-[[2-chloro-3-(trifluoromethyl)benzyl](2,2-dephenylethyl)amino]propoxy}phenyl)-ethanol; agonists of the nuclear receptors, LXR alpha and LXR beta used to increase ABCA1, ABCG1, and apolipoprotein E expression and inhibiting cholesterol absorption
05/26/2005US20050113400 Novel benzophenone derivatives or salts thereof
05/26/2005CA2543913A1 Benzylether amine compounds useful as ccr-5 antagonists
05/25/2005EP1532209A2 Charge transport compositions and electronic devices made with such compositions
05/25/2005EP1532099A1 Preparation of secondary amines
05/25/2005EP1532089A1 Fluorene compound and organic luminescent device using the same
05/25/2005EP1282592B1 Use of amines
05/25/2005CN1620461A 2-amino-propanol derivatives
05/25/2005CN1620421A Substituted alkyl diamine
05/25/2005CN1620420A Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
05/25/2005CN1203048C 3,5-bi(3-hydroxy-4-aminophenoxy)benzoic acid and its hydrochlorides and preparation thereof
05/25/2005CN1203047C Biaryl ether derivatives useful as monoamine reuptake inhibitors
05/25/2005CN1203046C Substituted amine-link compound for reverse flotation of bauxite
05/25/2005CN1202815C Delayed-action form of administration containing tramadol saccharinate
05/24/2005US6897341 Bis(aminostyryl)naphthalene compound, synthesis intermediate thereof, and process for production thereof
05/24/2005US6897276 Coordination polymerization catalyst for alpha-olefins
05/19/2005WO2005044787A1 Phenetanolamine derivatives
05/19/2005US20050107637 Catalysts and method for the production of amines
05/19/2005US20050107635 Metoprolol manufacturing process
05/19/2005US20050107448 Calcium receptor antagonists
05/18/2005EP1530562A1 Optically active 1-(fluoro-,trifluoromethyl-or trifluoromethoxy-substituted phenyl)alkylamine n-monoalkyl derivatives and process for producing same
05/18/2005EP1530462A1 1-phenyl-2-dimethylaminomethyl cyclohexane compounds used for the therapy of depressive symptoms, pain, and incontinence
05/18/2005CN1617854A Pheny(alkyl)carboxylic acid derivatives and dionic phenylalkylheterocyclic derivatives and their use as medicines with serum glucose and/or serum lipid lowering activity
05/18/2005CN1617848A Crystalline venlafaxine base and novel polymorphs of venlafaxine hydrochloride, processes for preparing thereof
05/18/2005CN1617846A Production method of (r)-3- hydroxy-3-(2-phenylethyl)hexanoic acid and intermediate thereof
05/18/2005CN1616455A Processes for producing 7-isoindoline-quinolonecarboxylic acid derivative and its intermediate
05/18/2005CN1616412A Process for the preparation of halogen containing 4-amino phenols
05/18/2005CN1202093C Substituted heterocyclic compound
05/18/2005CN1202052C Enantioselective reduction of ketones with silane agent/metal compound/chiral ligand system
05/17/2005US6894191 Reacting arylamine with aromatic halide in presence of catalyst and base
05/17/2005US6894190 Process for producing optically active 3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid, and salt thereof
05/12/2005WO2005042467A1 Quaternary amino-functional chalcones
05/12/2005WO2005042466A1 Quaternary ammonium salt, electrolyte, electrolyte solution and electrochemical device
05/12/2005WO2005042465A1 Omega-substituted-naphthyloxyalklamino derivatives as antihyperglycemic agents and preparation
05/12/2005WO2005019164A3 Preparation of phenethanolamine derivatives
05/12/2005WO2004087061B1 Tubulin binding agents and corresponding prodrug constructs
05/12/2005US20050101756 Flexible isopropylidene and tetramethyl-containing fluoropolyamide and fluoropolyimide and preparation method thereof
05/12/2005US20050101644 Benzylether amine compounds useful as CCR-5 antagonists
05/12/2005US20050101610 Antiischemic agents; brain disorders; cardiovascular disorders; for the alleviation or treatment of symptoms due to neurodegenerative diseases and symptoms derived from diabetes, arteriosclerosis and inflammatory diseases ; for example, N-tert-butoxycarbonyl-4-[4-(4-fluorophenoxy)phenyl]-4-piperidinol
05/12/2005US20050100805 Electrophotographic photosensitive member, process cartridge and electrophotographic apparatus
05/12/2005US20050100527 Liposomes for transfection of nucleic acids
05/11/2005EP1529037A2 Synthesis of 2-alkylcysteines, 2-(hydroxylated phenyl)-4-alkylthiazoline-4-carboxylic acids and derivatives thereof
05/11/2005CN1613844A Chiral 1, 4 diamidogen and its complex of platinum II
05/11/2005CN1200700C Pharmaceutical tramadol salts
05/10/2005US6891067 Optical polyimide precursor, optical polyimide compound and fabricating method thereof
05/10/2005US6890994 Curable coating compositions with carbamate-containing acrylic polymers
05/10/2005US6890955 Drugs for treating obesity and diabetes and animal feed additives
05/10/2005US6890952 Administering cyclic substituted aminomethyl compounds for the preparation of a drug for the treatment of pain, urinary incotinence, itching, tinnitus aurium or diarrhea in a mammal
05/10/2005US6890920 Therapeutic treatment of asthma, chronic obstructive pulmonary disease, rhinorrhea due to the common cold, rhinitis
05/06/2005WO2005040104A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
05/06/2005WO2005040103A1 Medicinal compounds
05/06/2005WO2005040102A2 Novel compounds and their use as antidiabetic and hypolipidemic agents, process for their preparation and pharmaceutical compositions containing them
05/06/2005WO2004002939A3 Aminoalcohol derivatives
05/06/2005CA2538630A1 Novel compounds and their use in medicine: process for their preparation and pharmaceutical compositions containing them
05/05/2005US20050096485 Thyronamine derivatives and analogs and methods of use thereof
05/05/2005US20050096397 Adding trifluoroacetic acid dropwise to a solution of dimethylphenylsilane and (S)-amino-1-(2,5-dimethoxy-phenyl)-1-propanone, the amino group of which is protected, for example, with a methoxycarbonyl group; reduction; deprotecting; salt formation
05/05/2005US20050096394 Racemic tamsulosin free base in solid state; preparation by precipitating the free base with a base from an acid addition salt in a water and/or a lower alcohol solvent
05/05/2005US20050096384 Compounds and methods for treating breast cancer and other diseases
05/04/2005EP1527775A1 Controlled release formulation containing tramadol
05/04/2005EP1527043A1 Method for the production of 2- (dimethylamino)methyl]-1-(3-methoxyphenyl)cyclohexanol
05/04/2005EP1527042A2 Method for producing aminoalkoxy benzylamines and aminoalkoxy benzonitriles as intermediates
05/04/2005EP1527041A1 Process for the preparation of primary amines
05/04/2005EP1526917A2 Novel nickel-carbene, palladium-carbene and platinum-carbene complexes, their production and use in catalytic reactions
05/04/2005EP1246790B1 Substituted 1 and 2 naphthol mannich bases
05/04/2005EP1159254B1 Oxyalkylene-substituted aminophenol intermediate
05/04/2005EP0958280B1 Arylpiperidinopropanol and arylpiperazinopropanol derivatives and pharmaceuticals containing the same
05/04/2005CN1612871A Processes and intermediates for preparing benzyl epoxides
05/04/2005CN1612852A Lipoxin A4 analogs
05/04/2005CN1611489A Intermediates for the synthesis of benzimidazole compounds and process for preparation thereof
05/04/2005CN1199936C Process for synthesizing 4-amino-chlorodiphenyl methane as intermediate of dye
05/03/2005US6888029 Arylation complex catalyst
05/03/2005US6887871 Use of phenylheteroakylamine derivatives
05/03/2005US6887820 Method for producing optically active compounds
04/2005
04/28/2005WO2005037810A2 Cyclopropyl methanone derivatives, the preparation and the therapeutic use thereof
04/28/2005WO2005023744A3 Calixarenes as inhibitors of protein kinase b
04/28/2005WO2005012227A3 Process for preparation of 2-(3-diisopropylamino-1-phenylpropyl)-4-hydroxymethyl-phenol, a metabolite of tolterodine
04/28/2005US20050090669 Aminoalcohol derivatives as beta-3 adrenergic receptor agonists
04/28/2005US20050090555 Compound for the treatment of metabolic disorders
04/27/2005CN1610547A N-(2-arylethyl)benzylamines as antagonists of the 5-HT6 receptor
04/27/2005CN1199296C Hole transferring agent and photoelectric conversing device containing it
1 ... 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 ... 140